Quercetin and Quercetin for Senolytic (healthspan)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Quercetin
A flavonoid with modest blood-pressure data, a senolytic research role, and poor absorption to overcome.
Grade C2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Quercetin for Senolytic (healthspan)
Evidence grade D — Experimental, drug-paired
Grade D1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Quercetin | Quercetin for Senolytic (healthspan) |
|---|---|---|
| Senolytic (healthspan) | Evidence grade DUnclear effectlowExperimental, drug-paired | Evidence grade DUnclear effectlowExperimental, drug-paired |
Graded only in Quercetin
- Blood pressure Small effectEvidence grade C
Graded only in Quercetin for Senolytic (healthspan)
None — every outcome it grades is graded in both.
What each entry says about the other
- Quercetin for Senolytic (healthspan)’s entry · Goes with: Read the full Quercetin monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.